Brief: Serina Therapeutics Board Appointed Gregory Curhan As Co's CFO In Non-Employee Consultant Role
16/08/2024 11:17
Aug 16 (Reuters) - Serina Therapeutics Inc SER.A :
* SERINA THERAPEUTICS: BOARD APPOINTED GREGORY S. CURHAN AS
CO'S
CFO IN NON-EMPLOYEE CONSULTANT ROLE
Source text for Eikon: ID:n0001493152-24-032700
Further company coverage: SER.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on Serina Therapeutics
See all newsBrief: Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2
Brief: Serina Therapeutics - Offers Up To 12,500,000 Shares Of Common Stock By Roth Principal Investments - SEC Filing
Serina Therapeutics Q2 net loss widens on higher expenses
Brief: Serina Therapeutics Appoints Farrell Simon To Its Board Of Directors
Brief: Serina Therapeutics Completes Sentinel Dosing In Cohort 1 Of Phase 1B Registrational Trial Of SER-252